Exact Sciences
EXAS
#1383
Rank
C$17.75 B
Marketcap
$96.07
Share price
2.34%
Change (1 day)
-5.23%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of June 2024 : C$4.33 B

According to Exact Sciences's latest financial reports the company has C$4.33 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$4.17 B1.03%
2022-12-31$C$4.12 B-3.68%
2021-12-31$C$4.28 B50.39%
2020-12-31$C$2.85 B-3.89%
2019-12-31$C$2.96 B219.31%
2018-12-31$C$0.92 B41.97%
2017-12-31$C$0.65 B45.21%
2016-12-31$C$0.45 B-0.73%
2015-12-31$C$0.45 B35.42%
2014-12-31$C$0.33 B132.83%
2013-12-31$C$0.14 B46.5%
2012-12-31$C$98.26 M15.7%
2011-12-31$C$84.93 M6.39%
2010-12-31$C$79.83 M1143.47%
2009-12-31$C$6.42 M-315.96%
2008-12-31$-C$2.98 M-148.22%
2007-12-31$C$6.16 M-64.6%
2006-12-31$C$17.41 M-39.24%
2005-12-31$C$28.66 M-30.84%
2004-12-31$C$41.44 M158.56%
2003-12-31$C$16.02 M-73.54%
2002-12-31$C$60.56 M-35.52%
2001-12-31$C$93.93 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$1.00 B-76.80%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.53 B-64.52%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.39 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
C$106.13 B 2,351.21%๐Ÿ‡ซ๐Ÿ‡ท France